![Andrew Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Cheng
Director/Board Member at
VERA THERAPEUTICS, INC.
Net worth: 561 365 $ as of 2026-06-29
Profile
Andrew Cheng is currently Chairman, President & Chief Executive Officer at Avere Therapeutics, Inc. Dr. Cheng serves as Independent Director at Vera Therapeutics, Inc. since 2017.
Dr. Cheng is Director at Boys & Girls Clubs of Metro Los Angeles.
Dr. Cheng is Independent Director at TCGX Acquisition Corp.
starting in 2026.
Formerly, Dr. Cheng was President, Chief Executive Officer & Director at Akero Therapeutics, Inc. from 2018 to 2025.
Dr. Cheng was Independent Director at Arbutus Biopharma Corp.
from 2019 to 2022.
Dr. Cheng was Director at Syntimmune, Inc. Dr. Cheng was Director at Global Virus Network.
Dr. Cheng was Non-Executive Director at MorphoSys AG from 2022 to 2024.
Dr. Cheng was Chief Medical Officer & Executive Vice President at Gilead Sciences, Inc. in 2018.
Dr. Cheng completed undergraduate studies at The Johns Hopkins University in 1988.
Dr. Cheng earned a doctorate from Columbia University College of Physicians & Surgeons in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-20 | 17,488 ( 0.02% ) | 561 365 $ | 2026-07-30 | |
1.39% | 2026-08-03 | 30,000 ( 1.39% ) | 0 $ | 2026-06-29 |
Andrew Cheng active positions
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Director/Board Member | 2017-04-30 |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Operates as a Non-profit organization that provides proven programming services | Director/Board Member | - |
Former positions of Andrew Cheng
| Companies | Position | End |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Chief Executive Officer | 2025-12-08 |
| MORPHOSYS AG | Director/Board Member | 2024-06-05 |
| ARBUTUS BIOPHARMA CORPORATION | Director/Board Member | 2022-05-24 |
| GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2018-09-06 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Director/Board Member | - |
Training of Andrew Cheng
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Boys & Girls Clubs of Metro Los Angeles
Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Operates as a Non-profit organization that provides proven programming services | Commercial Services |
- Stock Market
- Insiders
- Andrew Cheng
